Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma

Pediatric Blood and Cancer

Volumn 60, Issue 7, 2013, Pages 1128-1134

  Federico, Sara M ^a,b   Spunt, Sheri L ^a,b   Krasin, Matthew J ^a   Billup, Catherine A ^a   Wu, Jianrong ^a   Shulkin, Barry ^a   Mandell, Gerald ^a   Mccarville, M Beth ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Conventional imaging; Diagnosis; PET CT; Rhabdomyosarcoma; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; IODINATED CONTRAST MEDIUM;

ADOLESCENT; ADULT; ARTICLE; BONE DISEASE; BONE MARROW DISEASE; BONE MARROW EXAMINATION; CANCER DIAGNOSIS; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONVENTIONAL IMAGING; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LUNG NODULE; LYMPH NODE; MALE; PET SCANNER; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOFT TISSUE METASTASIS;

CHILD; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA;

EID: 84878224309     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24430     Document Type: Article

References (26)

1. Gurney JG, Davis S, Severson RK, et al. Trends in cancer incidence among children in the U.S. Cancer 1996; 78: 532-541.
2. Ferrari A, Sultan I, Huang TT, et al. Soft tissue sarcoma across the age spectrum: A population-based study from the Surveillance Epidemiology and End Results database. Pediatr Blood Cancer 2011; 57: 943-949.
3. Wexler LH, Meyer WH, Helman LJ. Rhabdomyosarcoma. In: Pizzo PA, Poplack DG, editors. Priniciples and practice of pediatric oncology, 6th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. pp 923-953.
4. Oberlin O, Rey A, Lyden E, et al. Prognostic factors in metastatic rhabdomyosarcomas: Results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 2008; 26: 2384-2389.
5. Guillerman RP, McCarville MB, Kaste SC, et al. Imaging studies in the diagnosis and management of pediatric malignancies. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 6th edition. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. pp 216-278.
6. McCarville MB, Christie R, Daw NC, et al. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005; 184: 1293-1304.
7. Baum SH, Frühwald M, Rahbar K, et al. Contribution of PET/CT to prediction of outcome in children and young adults with rhabdomyosarcoma. J Nucl Med 2011; 52: 1535-1540.
8. Volker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial. J Clin Oncol 2007; 25: 5435-5441.
9. Arush MW, Israel O, Postovsky S, et al. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Pediatr Blood Cancer 2007; 49: 901-905.
10. Arush MW, Bar Shalom R, Postovsky S, et al. Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. J Pediatr Hematol Oncol 2006; 28: 440-445.
11. Tateishi U, Hosono A, Makimoto A, et al. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med 2009; 23: 155-161.
12. Klem ML, Grewal RK, Wexler LH, et al. PET for staging in rhabdomyosarcoma: An evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol 2007; 29: 9-14.
13. Mody RJ, Bui C, Hutchinson RJ, et al. FDG PET imaging of childhood sarcomas. Pediatr Blood Cancer 2010; 54: 222-227.
14. Ricard F, Cimarelli S, Deshayes E, et al. Additional benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma. Clin Nucl Med 2011; 36: 672-677.
15. Schuetze SM. Utility of positron emission tomography in sarcomas. Curr Opin Oncol 2006; 18: 369-373.
16. Lucas JD, O'Doherty MJ, Cronin BF, et al. Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg 1999; 86: 550-556.
17. Goodin GS, Shulkin BL, Kaufman RA, et al. PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease. AJR Am J Roentgenol 2006; 187: 1124-1128.
18. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
19. Simel DL, Feussner JR, DeLong ER, et al. Intermediate, indeterminate, and uninterpretable diagnostic test results. Med Decis Making 1987; 7: 107-114.
20. Meza JL, Anderson J, Pappo AS, et al. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: The Children's Oncology Group. J Clin Oncol 2006; 24: 3844-3851.
21. Rodeberg DA, Garcia-Henriquez N, Lyden ER, et al. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: A report from the Children's Oncology Group. J Clin Oncol 2011; 29: 1304-1311.
22. Seshadri N, Wright P, Balan KK. Rhabdomyosarcoma with widespread bone marrow Infiltration. Clin Nuc Med 2007; 32: 787-789.
23. 18F-18 FDG PET/CT and bone marrow biopsy. Eur J Nucl Med Mol Imaging 2008; 35: 1746.
24. Coleman RE, Laymon CM, Turkington TG. FDG imaging of lung nodules: A phantom study comparing SPECT, camera-based PET, and dedicated PET. Radiology 1999; 210: 823-828.
25. D'Angelo P, Carli M, Ferrari A, et al. Breast metastases in children and adolescents with rhabdomyosarcoma: Experience of the Italian Soft Tissue Sarcoma Committee. Pediatr Blood Cancer 2010; 55: 1306-1309.
26. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247.